Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Biological control to manage plant diseases is an environmentally friendly alternative to using chemical pesticides. However, little is known about the role of genetic variation in plants affecting the efficacy of biological control agents (BCAs). The aim of this study was to explore the genetic variation in winter wheat for disease susceptibility to fusarium foot rot caused by Fusarium graminearum and variation in biocontrol efficacy of the fungal BCA Clonostachys rosea to control the disease. In total, 190 winter wheat genotypes were evaluated under controlled conditions in two treatments, i.e. (i) F. graminearum (Fg) and (ii) F. graminearum infection on C. rosea treated seeds (FgCr). Alongside disease severity, plant growth-related traits such as shoot length and root length were also measured. Comparison of genotypes between the two treatments enabled the dissection of genotypic variation for disease resistance and C. rosea efficacy. The study revealed significant variation among plant genotypes for fusarium foot rot susceptibility and other growth traits in treatment Fg. Moreover, significant variation in C. rosea efficacy was also observed in genotype contrasts between the two treatments for all traits. Using a 20K marker array, a genome-wide association study was also performed. We identified a total of 18 significant marker-trait associations for disease resistance and C. rosea efficacy for all the traits. Moreover, the markers associated with disease resistance and C. rosea efficacy were not co-localized, highlighting the independent inheritance of these traits, which can facilitate simultaneous selection for cultivar improvement.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11631536PMC
http://dx.doi.org/10.1093/g3journal/jkae240DOI Listing

Publication Analysis

Top Keywords

rosea efficacy
16
winter wheat
12
fusarium foot
12
foot rot
12
disease resistance
12
resistance rosea
12
genotypic variation
8
variation winter
8
clonostachys rosea
8
biological control
8

Similar Publications

This study investigated the efficacy of two microalgae treatment systems (Chlorella vulgaris monoculture and a Chlorella vulgaris-S395-2-Clonostachys rosea symbiotic system) in treating aquaculture wastewater, under varying concentrations of synthetic strigolactone analog (GR24). By exposing the systems to four GR24 doses (0, 10, 10, and 10 M), we examined the impact on biomass growth, photosynthesis, and wastewater treatment. Elevated GR24 concentrations bolstered metabolism and photosynthesis in the systems, fostering rapid symbiont growth and enhanced treatment efficiency.

View Article and Find Full Text PDF

Background: Aitchisonia rosea (A. rosea), traditionally used for oxidative stress-related conditions, lacks comprehensive scientific validation of its antioxidant mechanisms and cellular protective effects. This study aimed to meticulously investigate the phytochemical composition, in vitro antioxidant capacity, and protective efficacy of A.

View Article and Find Full Text PDF

Introduction: Melanoma is the most common cause of skin cancer-related deaths due to its aggressive nature. Plant-derived exosome-like nanovesicles (PELNs) are promising natural nanoparticles for therapeutic applications owing to their biocompatibility and diverse bioactive components. However, research on Rhodiola rosea-derived exosome-like nanovesicles (RELNs) remains limited.

View Article and Find Full Text PDF

Introduction: L., mainly known within the medicinal plant industry as golden root, Arctic root, or rose root, derives its name from its economic significance, distinctive morphology, and restricted geographical distribution. Extracts from roots/rhizomes are widely used across Europe and Asia as ingredients of traditional herbal medicines and dietary supplements, with numerous claims regarding their adaptogenic effects.

View Article and Find Full Text PDF

Introduction: To evaluate the efficacy and safety of extract (RCE) for the treatment of patients with acute high altitude disease (AHAD).

Methods: This study systematically retrieved randomized controlled trials (RCTs) published prior to September 2024 from eight distinct databases. It included AHAD patients, with the control group receiving either conventional western medicine (WM) or placebo, and the experimental group receiving RCE alone or in conjunction with WM.

View Article and Find Full Text PDF